StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.78−0.07 (-3.78%)

Close on Nov 17, 2026Market cap $54.27MP/E –Yield –

XBiotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

XBiotech's operating income for the twelve months ending Jun 30, 2026 was -$48.22M. For fiscal 2025 it was -$55.69M. The highest annual figure on record is -$9.93M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$55.69M–
FY2024Dec 31, 2024-$42.47M–
FY2023Dec 31, 2023-$37.51M–
FY2022Dec 31, 2022-$34.49M–
FY2021Dec 31, 2021-$25.08M–
FY2020Dec 31, 2020-$18.28M–
FY2019Dec 31, 2019-$31.23M–
FY2018Dec 31, 2018-$20.99M–
FY2017Dec 31, 2017-$34.06M–
FY2016Dec 31, 2016-$52.76M–
FY2015Dec 31, 2015-$37.51M–
FY2014Dec 31, 2014-$21.78M–
FY2013Dec 31, 2013-$9.93M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.15M–
Q1 FY2026Mar 31, 2026-$6.27M–
Q4 FY2025Dec 31, 2025-$29.76M–
Q3 FY2025Sep 30, 2025-$6.05M–
Q2 FY2025Jun 30, 2025-$6.34M–
Q1 FY2025Mar 31, 2025-$13.55M–
Q4 FY2024Dec 31, 2024-$8.75M–
Q3 FY2024Sep 30, 2024-$7.90M–
Q2 FY2024Jun 30, 2024-$14.97M–
Q1 FY2024Mar 31, 2024-$10.85M–
Q4 FY2023Dec 31, 2023-$8.59M–
Q3 FY2023Sep 30, 2023-$8.52M–
Q2 FY2023Jun 30, 2023-$13.26M–
Q1 FY2023Mar 31, 2023-$7.15M–
Q4 FY2022Dec 31, 2022-$8.16M–
Q3 FY2022Sep 30, 2022-$6.39M–
Q2 FY2022Jun 30, 2022-$12.09M–
Q1 FY2022Mar 31, 2022-$7.85M–
Q4 FY2021Dec 31, 2021-$7.19M–
Q3 FY2021Sep 30, 2021-$3.73M–
Q2 FY2021Jun 30, 2021-$10.61M–
Q1 FY2021Mar 31, 2021-$3.55M–
Q4 FY2020Dec 31, 2020-$4.92M–
Q3 FY2020Sep 30, 2020-$4.67M–
Q2 FY2020Jun 30, 2020-$6.51M–
Q1 FY2020Mar 31, 2020-$2.17M–
Q4 FY2019Dec 31, 2019-$13.31M–
Q3 FY2019Sep 30, 2019-$6.11M–
Q2 FY2019Jun 30, 2019-$6.01M–
Q1 FY2019Mar 31, 2019-$5.81M–
Q4 FY2018Dec 31, 2018-$6.11M–
Q3 FY2018Sep 30, 2018-$5.12M–
Q2 FY2018Jun 30, 2018-$5.62M–
Q1 FY2018Mar 31, 2018-$4.15M–
Q4 FY2017Dec 31, 2017-$7.51M–
Q3 FY2017Sep 30, 2017-$6.59M–
Q2 FY2017Jun 30, 2017-$9.69M–
Q1 FY2017Mar 31, 2017-$10.27M–
Q4 FY2016Dec 31, 2016-$16.44M–
Q3 FY2016Sep 30, 2016-$12.46M–

More XBiotech figures

See a number that looks wrong?